New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Nautilus Biotechnology, Inc.
NAUT
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

359M

Biotechnology

Next Earning date - 29 Oct 2024

359M

Biotechnology

Next Earning date - 29 Oct 2024

2.86USD
Shape0.15 ( 5.54%)
favorite-chart

Relative Strenght

25
favorite-chart

Volume Buzz

-1%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

17%

Quote Panel

Shape
Updated October 12, 2024
1W 7.52 % 1M -1.38 % 3M 9.58 % 1Y 0.00 %

Key Metrics

Shape
  • Market Cap

    358.68M


  • Shares Outstanding

    125.41M


  • Share in Float

    74.99M


  • Dividende

    0


  • Earning Date

    29 Oct 2024


  • Price Target

    2.86


  • Average Volume

    71334


  • Beta

    1.027


  • Range

    2.19-3.455


  • Industry

    Biotechnology


  • Website

    https://www.nautilus.bio


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

43.68x

P/S Ratio

1.52x

P/B Ratio

0.1

Debt/Equity

-848.1%

Net Margin

$-0.6

EPS

How NAUT compares to sector?

P/E Ratio

Relative Strength

Shape

NAUT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$11M

ShapeNaN%

2025-Revenue

$0.82

Shape-483%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Guggenheim

initialise

Previous: Not converted

2024-06-27

Now: Buy

Jefferies

downgrade

Previous: Not converted

2024-06-03

Now: Hold

Zacks Investment Research

downgrade

Previous: Not converted

2022-04-26

Now: Sell

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.11
vs -0.12

Q4.22

arrow
arrow

N/A

-0.11
vs -0.13

Q1.23

arrow
arrow

N/A

-0.12
vs -0.13

Q2.23

arrow
arrow

N/A

-0.13
vs -0.12

Q3.23

arrow
arrow

N/A

-0.13
vs -0.11

Q4.23

arrow
arrow

N/A

-0.14
vs -0.11

Q1.24

arrow
arrow

N/A

-0.15
vs -0.12

Q2.24

arrow
arrow

N/A

-0.14
vs -0.13

Q3.24

arrow
arrow

N/A

-0.17
vs -0.13

Q4.24

arrow
arrow

N/A

-0.17
vs -0.14

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

8.2M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

1.8M  vs NA

Q4.24

arrow
arrow

-98%

153.3K  vs 8.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-4%

-0.04
vs -0.04

Q4.22

arrow
arrow

-5%

-0.05
vs -0.04

Q1.23

arrow
arrow

-4%

-0.04
vs -0.05

Q2.23

arrow
arrow

-5%

-0.05
vs -0.04

Q3.23

arrow
arrow

-6%

-0.06
vs -0.05

Q4.23

arrow
arrow

-6%

-0.06
vs -0.06

Q1.24

arrow
arrow

-8%

-0.08
vs -0.06

Q2.24

arrow
arrow

-8%

-0.08
vs -0.08

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

83

83
vs 82

1%

Q4.22

arrow
arrow

79

79
vs 83

-5%

Q1.23

arrow
arrow

78

78
vs 79

-1%

Q2.23

arrow
arrow

77

77
vs 78

-1%

Q3.23

arrow
arrow

77

77
vs 77

NA

Q4.23

arrow
arrow

77

77
vs 77

NA

Q1.24

arrow
arrow

72

72
vs 77

-6%

Q2.24

arrow
arrow

76

76
vs 72

6%

Earnings Growth

Latest News